Fig. 13From: Systematic analysis of integrated bioinformatics to identify upregulated THBS2 expression in colorectal cancer cells inhibiting tumour immunity through the HIF1A/Lactic Acid/GPR132 pathwayImmunosuppressive phenotype induced by high expression of THBS2 depends on GPR132 expression. A Establishment of GPR132-KO and tumour-bearing Balb/c mouse models; B Assessment of tumour size 30 days after the injection of CT26 and CT26-THBS2 cells in mice; C Flow cytometric analysis of CD3 + /CD8 + and TIM3 + /PD1 + cell abundance in tumour tissues of different groups. D Flow cytometric analysis of F4/80 + /CD11b + , CD163 + and CD206 + cell abundance in tumour tissues of different groups; E Flow cytometric analysis of CFSE in CD8 + T cellsBack to article page